[On the applicability of cosaldon in the treatment of cerebral sclerotic parkinsonism].
D004338:Drug Combinations; D009525:Niacin / Q000628:therapy*; D009539:Nicotinic Acids; D010300:Parkinson Disease / Q000628:therapy*; D020734:Parkinsonian Disorders; D013805:Theobromine / Q000031:analogs & derivatives; D014665:Vasodilator Agents / Q000628:therapy*
D004338:Drug Combinations; D009539:Nicotinic Acids; D014665:Vasodilator Agents; C007138:nicotinic acid, pentifylline drug combination; D009525:Niacin; D013805:Theobromine
NICOTINIC ACID/therapy; PARALYSIS AGITANS/therapy; VASODILATOR AGENTS/therapy